// App-Quantinova.ai

: CYP24A1 Mutation Masking Malignancy Mediated Hypercalcemia

Researchers

Presenter

  • Cheng Cheng

Principal Investigators

  • Chienying Liu

  • Daniel D Bikle

  • Dolores M Shoback

Medical Centers

  • WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, St Louis, MO, USA

  • University of California, San Francisco, San Francisco, CA

  • VA Med Ctr 111N-UCSF, San Francisco, CA, USA

  • UCSF/VA Med Ctr, San Francisco, CA, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Genetic Disorder

  • Urology

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

Disease

  • Hypercalcemia infantile

  • Non-Hodgkin's Lymphoma

  • Obstructive uropathy

  • Non‐Hodgkin Lymphoma

  • Follicular lymphoma

  • Hodgkin's Lymphoma

  • Nephrolithiasis, calcium oxalate

  • Hypercalcaemia

  • Lymphomas

Biomarkers

  • Parathyroid Hormone

  • Cytochrome P450 family 24 subfamily A member 1

Drug/Treatment

  • Parathyroid hormone

  • Prednisone

  • Ergocalciferol

  • Rituximab

  • PTHrP

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved